Quote:
Originally Posted by Edward64
I dunno.
50% fatality rate (if holds true from the small sample size) will get people on board. There'll still be some crazies but a vaccine won't get here fast enough for 95% of the population.
|
Good proactive move.
https://www.reuters.com/business/hea...es-2023-03-20/
Quote:
|
Executives at three vaccine manufacturers – GSK Plc (GSK.L) Moderna Inc (MRNA.O) and CSL Seqirus, owned by CSL Ltd (CSL.AX) - told Reuters they are already developing or about to test sample human vaccines that better match the circulating subtype, as a precautionary measure against a future pandemic.
|
And the same old dilemma as with the Covid vaccines
Quote:
Less reassuring, however, is that most of the potential human doses are earmarked for wealthy countries in long-standing preparedness contracts, global health experts and the companies said.
Many countries' pandemic plans say flu shots should go first to the most vulnerable while supply is limited. But during COVID-19, many vaccine-rich countries inoculated large proportions of their populations before considering sharing doses.
|